title: Expression, regulation, and function of alpha V integrins in hepatocellular carcinoma: an in vivo and in vitro study.
abstract: The expression of alpha V integrins by neoplastic cells contributes to the promotion of local invasion and metastasis. The most characteristic extracellular ligands of alpha V integrins are vitronectin and fibronectin. Hepatocytes are the main source of vitronectin, and the capacity to synthesize and secrete vitronectin is usually retained in hepatocellular carcinoma. The aim of this study was to explore the expression, regulation, and functional role of alpha V integrins in hepatocellular carcinoma. We first analyzed the expression of alpha V integrins and their ligands fibronectin and vitronectin in 80 cases of hepatocellular carcinoma. alpha V integrin chain was detected in 44 cases and vitronectin in 50. Twenty-four of the 44 alpha V-positive tumors contained large amounts of vitronectin. These cases presented more frequently with adverse histoprognostic factors, including infiltrative growth pattern (62.5%), lack of capsule (71%), presence of capsular invasion (57%), and satellite nodules (50%). We then used HepG2 and Hep3B cell lines as in vitro models to study alpha V integrin regulation and function. HepG2 and Hep3B cells expressed alpha V integrin chain and used alpha V beta 1 and alpha V beta 5 for adhesion and migration on vitronectin. Tumor necrosis factor (TNF) alpha and transforming growth factor (TGF) beta significantly increased the expression levels of alpha V integrins and stimulated the adhesion and migration of both HepG2 and Hep3B cell lines on vitronectin. The effects of growth factors on cell adhesion and migration were reproduced by incubation with conditioned medium from rat liver myofibroblasts. In conclusion, our results support the existence of an alpha V integrin/vitronectin connection in hepatocellular carcinoma and suggest that this connection may be an adverse prognostic factor.
authors.affiliation: Unité INSERM U45, Hôpital Edouard Herriot, Lyon, France.
authors.forename: Mimoun
authors.initials: M
authors.lastname: Nejjari
authors.forename: Zakia
authors.initials: Z
authors.lastname: Hafdi
authors.forename: Géraldine
authors.initials: G
authors.lastname: Gouysse
authors.forename: Michelangelo
authors.initials: M
authors.lastname: Fiorentino
authors.forename: Olivier
authors.initials: O
authors.lastname: Béatrix
authors.forename: Jérôme
authors.initials: J
authors.lastname: Dumortier
authors.forename: Céline
authors.initials: C
authors.lastname: Pourreyron
authors.forename: Chiara
authors.initials: C
authors.lastname: Barozzi
authors.forename: Antonia
authors.initials: A
authors.lastname: D'errico
authors.forename: Walter F
authors.initials: WF
authors.lastname: Grigioni
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Scoazec
mesh_terms: D000328:Adult; D000368:Aged; D015703:Antigens, CD / Q000032:analysis / Q000096:biosynthesis / Q000378:metabolism*; D006528:Carcinoma, Hepatocellular / Q000378:metabolism* / Q000473:pathology; D002448:Cell Adhesion; D002465:Cell Movement; D005260:Female; D005353:Fibronectins / Q000032:analysis / Q000096:biosynthesis / Q000378:metabolism; D020518:Focal Nodular Hyperplasia / Q000378:metabolism / Q000473:pathology; D022781:Hepatocytes / Q000737:chemistry / Q000166:cytology / Q000378:metabolism*; D006801:Humans; D066298:In Vitro Techniques; D039564:Integrin alphaV; D008113:Liver Neoplasms / Q000378:metabolism* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D014407:Tumor Cells, Cultured; D019096:Vitronectin / Q000032:analysis / Q000096:biosynthesis / Q000378:metabolism
chemical_list: D015703:Antigens, CD; D005353:Fibronectins; D039564:Integrin alphaV; D019096:Vitronectin